hC Bioscience
ClosedhC Bioscience was founded in 2021, is headquartered in Cambridge, United States, lists 11–50 employees, and has $40.0M in recorded funding across 2 rounds.
- Headquarters
- Cambridge, Massachusetts
- Employees
- 11–50
- Founded
- 2021
- Business Model
- B2B
- Website
- hcbioscience.com
- Total Funding
- $40.0M
- Last Round
- $16.0M Series ANov 2022
- Rounds
- 2
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 2 funding rounds and 4 investors for this company. The full record is or through the API.
About
hC Bioscience developed first-in-class tRNA-based therapeutics targeting protein dysfunction, aiming to improve patients' lives through the development of these treatments.
Summary
hC Bioscience is a Biotech company based in Cambridge, United States, founded in 2021. It lists 11–50 employees. It has raised $40.0M in total across 2 rounds, most recently a $16.0M Series A round in Nov 2022. Investors include ARCH Venture Partners, Takeda (JP) and 8VC.
Funding History
Nov 2022
Sign up to see all 2 events
Funding: Series A. Amounts, valuations, and investors where available.
Investors
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/hc-bioscience"><img src="https://indexed.vc/api/badge/company/hc-bioscience" alt="hC Bioscience on Indexed.vc" width="260" height="76" /></a>